医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
10期
1983-1985
,共3页
石顺华%廖春锋%傅广
石順華%廖春鋒%傅廣
석순화%료춘봉%부엄
酪氨酸/类似物和衍生物%心肌梗死/治疗%急性病%血管成形术 ,经腔 ,经皮冠状动脉
酪氨痠/類似物和衍生物%心肌梗死/治療%急性病%血管成形術 ,經腔 ,經皮冠狀動脈
락안산/유사물화연생물%심기경사/치료%급성병%혈관성형술 ,경강 ,경피관상동맥
Tyrosine/AA%Myocardial Infarction/TH%Acute Disease%Angioplasty,Translumi-nal,Percutaneous Coronary
【目的】研究国产替罗非班(欣维宁)在急性ST段抬高型心肌梗死患者行急诊直接经皮冠状动脉介入治疗(PCI)的疗效及安全性。【方法】入选2011~2012年急性ST 段抬高型心肌梗死患者46例,随机分为观察组和对照组各23例,观察组患者于冠脉造影(CAG)后PCI前持续静脉给予欣维宁,并追加肝素50 U/kg静脉注射,而对照组仅追加肝素100 U/kg静脉注射;比较两组患者罪犯血管开通情况,前向血流心肌梗死溶栓治疗试验分级(T IM I)及校正的T IM L计帧数;比较治疗前后48 h检查心电图变化及不良反应。【结果】观察组TIMI 3级获得率高于对照组(87%和74%,P<0.05),梗死的TIML计帧数(CTFC)明显低于对照组(22.5±4.6帧vs30.1±6.5帧,P<0.05),治疗后48h检查心电图相关导联ST段回落幅度较对照组大(P<0.05),缺血导联个数显著低于对照组(P <0.05),两组出血率无统计学意义(P >0.05)。【结论】急性心肌梗死患者急诊直接PCI术中联合应用欣维宁安全有效。
【目的】研究國產替囉非班(訢維寧)在急性ST段抬高型心肌梗死患者行急診直接經皮冠狀動脈介入治療(PCI)的療效及安全性。【方法】入選2011~2012年急性ST 段抬高型心肌梗死患者46例,隨機分為觀察組和對照組各23例,觀察組患者于冠脈造影(CAG)後PCI前持續靜脈給予訢維寧,併追加肝素50 U/kg靜脈註射,而對照組僅追加肝素100 U/kg靜脈註射;比較兩組患者罪犯血管開通情況,前嚮血流心肌梗死溶栓治療試驗分級(T IM I)及校正的T IM L計幀數;比較治療前後48 h檢查心電圖變化及不良反應。【結果】觀察組TIMI 3級穫得率高于對照組(87%和74%,P<0.05),梗死的TIML計幀數(CTFC)明顯低于對照組(22.5±4.6幀vs30.1±6.5幀,P<0.05),治療後48h檢查心電圖相關導聯ST段迴落幅度較對照組大(P<0.05),缺血導聯箇數顯著低于對照組(P <0.05),兩組齣血率無統計學意義(P >0.05)。【結論】急性心肌梗死患者急診直接PCI術中聯閤應用訢維寧安全有效。
【목적】연구국산체라비반(흔유저)재급성ST단태고형심기경사환자행급진직접경피관상동맥개입치료(PCI)적료효급안전성。【방법】입선2011~2012년급성ST 단태고형심기경사환자46례,수궤분위관찰조화대조조각23례,관찰조환자우관맥조영(CAG)후PCI전지속정맥급여흔유저,병추가간소50 U/kg정맥주사,이대조조부추가간소100 U/kg정맥주사;비교량조환자죄범혈관개통정황,전향혈류심기경사용전치료시험분급(T IM I)급교정적T IM L계정수;비교치료전후48 h검사심전도변화급불량반응。【결과】관찰조TIMI 3급획득솔고우대조조(87%화74%,P<0.05),경사적TIML계정수(CTFC)명현저우대조조(22.5±4.6정vs30.1±6.5정,P<0.05),치료후48h검사심전도상관도련ST단회락폭도교대조조대(P<0.05),결혈도련개수현저저우대조조(P <0.05),량조출혈솔무통계학의의(P >0.05)。【결론】급성심기경사환자급진직접PCI술중연합응용흔유저안전유효。
[Objective] To explore the efficacy and safety of domestic tirofiban in percutaneous coronary intervention(PCI) of patients with ST‐elevation myocardial infarction (STEMI) .[Methods] A total of 46 pa‐tients with STEMI from 2011 to 2012 were randomly divided into observation group ( n = 23) and control group( n=23) .The observation group was given continuously intravenous injection of tirofiban after coronary angiography(CAG) and before PCI ,and additional injection of heparin 50U/kg intravenously ,while the con‐trol group was given additional injection of heparin 100 u/kg intravenously .The patency of the diseased ves‐sels ,thrombolysis of anterior blood flow myocardial infarction trial classification (TIMI) and the corrected TIML number were compared between two groups .The 48h‐electrocardiogram change and adverse reaction before and after treatment were compared .[Results]The achievement ratio of TIMI grade 3 in observation group was higher than that in control group(87% vs .74% ,P<0 .05) .The infracted TIML number in obser‐vation group was obviously lower than that in control group [(22 .5 ± 4 .6) vs (30 .1 ± 6 .5) ,P <0 .05] .The falling extent of electrocardiogram‐related lead ST‐segment was obviously higher than that in control group( P<0 .05) .The number of ischemic lead in observation group was significantly lower than that in control ( P<0 .05) .There was no significant difference in hemorrhage rate between two groups ( P >0 .05) .[Conclusion]Tirofiban for the treatment of acute myocardial infarction during emergency direct PCI is safe and effective .